Based in London, United Kingdom, Dr Hakim is a Consultant Rheumatologist and Associate Professor in Medicine offering a comprehensive service managing rheumatic conditions in those aged 18 years and above. In addition, he has until recently been a Board member in Clinical Commissioning and a Trustee to the UK charity The Hypermobility Syndromes Association. In 2016 Dr Hakim joined the Medical and Scientific Board, The Ehlers-Danlos Society; also the Steering Committee of the International Consortium affiliated to The Ehlers-Danlos Society; and in July ’18 was appointed their Director of Education; then in August ’19 their Chief Medical Officer. In September ’18 Dr Hakim was appointed Adjunct Associate Professor in Medicine, Pennsylvania State University, USA.
*Important Notice About Dr Hakim’s Clinic: Please Visit The Clinic Appointments Page
Dr Hakim runs a private practice clinic. He is currently on sabbatical until summer 2020 but will continue to see his existing patients for follow-up. Please visit the Clinic Appointments page.
From Oct ’12 to Dec ’17 Dr Hakim was a Board member to the CWHHE Clinical Commissioning Group Collaborative in Westminster, Kensington & Chelsea, Hammersmith & Fulham, Hounslow, & Ealing.
Publications & Research.
Co-author of 5 medical books, chapters in major Rheumatology textbooks, and with over 100 publications, including original papers & reviews, Dr Hakim publishes & teaches widely in his field, and in September 2018 was honoured to be appointed Adjunct Associate Professor in Medicine, Pennsylvania State University, USA.
Charities & Clinical Leadership.
Dr Hakim was Trustee & Chief Medical Advisor to The Hypermobility Syndromes Association (HMSA) between 2012 and 2018; and is now a member of the Medical & Scientific Board, The Ehlers-Danlos Society, and their Director of Education, and Chief Medical Officer. He was from inception through to 2019 the Chair, and a faculty teacher with Pfizer iQ Leaders.